http://www.nitrc.org/forum/forum.php?forum_id=1705 October 6, 2010 Parkinson's Disease Therapeutics Conference The fourth annual Parkinson’s Disease Therapeutics conference, chaired by Franz Hefti, PhD - Scientific Advisory Board member of the Michael J. Fox Foundation for Parkinson’s Research and Chief Scientific Officer of Avid Radiopharmaceuticals in Philadelphia, Pennsylvania - will highlight novel advances in basic and translational research that impact our understanding of Parkinson’s Disease and its treatment. Speakers: Raymond T. Bartus, PhD, Ceregene, Inc.; Erwan Bezard, PhD, Université de Bordeaux; Gerard Griffioen, PhD, reMYND NV; Russell Katz, MD, US Food and Drug Administration; J. William Langston, MD, The Parkinson’s Institute; Patrick Little, PhD, Adolor Corporation; Kenneth Marek, MD, Institute for Neurodegenerative Disorders; Kalpana Merchant, PhD, Eli Lilly and Company; Jeremy R. Nichols, PhD, The Parkinson’s Institute; Gregory A. Petsko, PhD, Brandeis University; David E. Vaillancourt, PhD, University of Illinois at Chicago. en-us Copyright 2000-2026 NITRC OSI Fri, 17 Apr 2026 9:55:56 GMT http://blogs.law.harvard.edu/tech/rss NITRC RSS generator